{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:12:34Z","timestamp":1791389554946,"version":"4.3.3"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H04768"],"award-info":[{"award-number":["15H04768"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["15H04899"],"award-info":[{"award-number":["15H04899"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["18H02758"],"award-info":[{"award-number":["18H02758"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.radonc.2019.03.003","type":"journal-article","created":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T11:38:26Z","timestamp":1552995506000},"page":"100-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0977-8316","authenticated-orcid":false,"given":"Anussara","family":"Prayongrat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi M.","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Dekura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chie","family":"Toramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlakiet","family":"Khorprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Napapat","family":"Amornwichet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petch","family":"Alisanant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Shirato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.03.003_b0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","article-title":"Charged-particle therapy in cancer: clinical uses and future perspectives","volume":"14","author":"Durante","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10147-017-1190-2","article-title":"A systematic review of publications on charged particle therapy for hepatocellular carcinoma","volume":"23","author":"Igaki","year":"2018","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0020","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The quest for evidence for proton therapy: model-based approach and precision medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.radonc.2013.06.031","article-title":"The model-based approach to clinical studies in particle radiotherapy-a new concept in evidence based radiation oncology?","volume":"107","author":"Grau","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0030","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.ijrobp.2015.04.031","article-title":"Identification of patient benefit from proton therapy for advanced head and neck cancer patients based on individual and subgroup normal tissue complication probability analysis","volume":"92","author":"Jakobi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2015.12.029","article-title":"Development and evaluation of an online three-level proton vs photon decision support prototype for head and neck cancer \u2013 comparison of dose, toxicity and cost-effectiveness","volume":"118","author":"Cheng","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0045","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2307\/3583506","article-title":"Complication probability as assessed from dose-volume histograms","volume":"8","author":"Lyman","year":"1985","journal-title":"Radiat Res Suppl"},{"key":"10.1016\/j.radonc.2019.03.003_b0050","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0055","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(92)90651-W","article-title":"The use of 3-D dose volume analysis to predict radiation hepatitis","volume":"23","author":"Lawrence","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0060","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.ijrobp.2004.12.031","article-title":"Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease","volume":"62","author":"Cheng","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.11.034","article-title":"Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"65","author":"Xu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0070","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijrobp.2008.11.029","article-title":"Extrapolation of normal tissue complication probability for different fractionations in liver irradiation","volume":"74","author":"Tai","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0075","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0080","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2009.02.009","article-title":"Protons or photons for hepatocellular carcinoma? Let's move forward together","volume":"74","author":"Dawson","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0085","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1080\/0284186X.2017.1355113","article-title":"Impact of model and dose uncertainty on model-based selection of oropharyngeal cancer patients for proton therapy","volume":"56","author":"Bijman","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0090","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0095","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ijrobp.2003.10.052","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model: in regard to Dawson et al. IJROBP 2002;53:810-821","volume":"58","author":"Tome","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0100","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0360-3016(02)03986-X","article-title":"Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability","volume":"55","author":"Seppenwoolde","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0105","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0360-3016(91)90173-2","article-title":"Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations","volume":"21","author":"Kutcher","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0110","article-title":"An MLE method for finding LKB NTCP model parameters using Monte Carlo uncertainty estimates","volume":"489","author":"Carolan","year":"2014","journal-title":"J Phys: Conf Ser"},{"key":"10.1016\/j.radonc.2019.03.003_b0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.radonc.2009.02.003","article-title":"Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy","volume":"91","author":"Borst","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0120","doi-asserted-by":"crossref","first-page":"i50","DOI":"10.1093\/jrr\/rry018","article-title":"Assessing the uncertainty in a normal tissue complication probability difference (\u2206NTCP): radiation[HYPHEN]induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy","volume":"59","author":"Kobashi","year":"2018","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2019.03.003_b0125","series-title":"Statistical methods in medical research","author":"Armitage","year":"2001"},{"key":"10.1016\/j.radonc.2019.03.003_b0130","series-title":"A language and environment for statistical computing","author":"Development Core","year":"2010"},{"key":"10.1016\/j.radonc.2019.03.003_b0135","first-page":"48","article-title":"What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy","volume":"8","author":"Toramatsu","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0140","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1634\/theoncologist.2014-0097","article-title":"Radiation therapy for liver tumors: ready for inclusion in guidelines?","volume":"19","author":"Tanguturi","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2019.03.003_b0145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-8140(02)00061-0","article-title":"Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description","volume":"63","author":"Cheng","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2019.03.003_b0150","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0160","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0165","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0360-3016(00)01553-4","article-title":"Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland","volume":"50","author":"Schilstra","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0170","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.ijrobp.2013.06.2040","article-title":"Assessing the uncertainty in QUANTEC's dose-response relation of lung and spinal cord with a bootstrap analysis","volume":"87","author":"Wedenberg","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.003_b0175","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1093\/jrr\/rrx092","article-title":"Selection of external beam radiotherapy approaches for precise and accurate cancer treatment","volume":"59","author":"Shirato","year":"2018","journal-title":"J Radiat Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019301070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019301070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:08:07Z","timestamp":1759122487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019301070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"alternative-id":["S0167814019301070"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.03.003","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The normal tissue complication probability model-based approach considering uncertainties for the selective use of radiation modality in primary liver cancer patients","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}